Difference between revisions of "Team:IISc Bangalore"

Line 140: Line 140:
 
<h3>Overview</h3>
 
<h3>Overview</h3>
 
</div>  
 
</div>  
<p>of Our Project</p>
+
 
 
<div class="row">
 
<div class="row">
 
<div class="refer col-md-6">
 
<div class="refer col-md-6">
Line 157: Line 157:
 
<h3>Our Bioreactor Design</h3>
 
<h3>Our Bioreactor Design</h3>
 
</div>  
 
</div>  
<p>of Our Project</p>
+
 
 
<div class="row">
 
<div class="row">
 
<div class="refer col-md-6">
 
<div class="refer col-md-6">

Revision as of 21:16, 19 October 2016



Team IISc iGem



Overview

With the advent of rDNA technology in the late 1970s, medicine, agriculture and several other areas underwent a quantum leap and from that point, progress only hastened, from one only one recombinant pharmaceutical approved for human use (insulin) in 1982 to one hundred and fifty-one FDA approved protein based recombinant pharmaceuticals by 2009[1].
Read more

Our Bioreactor Design

We realized that manufacturing units use expensive and energy expensive machinery [3]. Hence, we engineered our bacteria in such a way that it could do most of the work done by these monstrous machines so that we no longer have to buy them and pay their bills.
Read more